COMMUNIQUÉS West-GlobeNewswire

CohBar Founder Dr. Nir Barzilai Awarded the 2018 Fondation IPSEN Longevity Prize

26/11/2018 - 15:00

Honored for his groundbreaking research on the determinants of longevity in human centenarians and associated models MENLO PARK, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage [...]

NRC Health Awards Annual Scholarship to UNL Students

26/11/2018 - 15:00

NRC Health awards Rising Stars Scholarship to successful business students and will recognize accomplishments at celebratory dinner LINCOLN, Neb., Nov. 26, 2018 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce [...]

Valens GroWorks Focused on the (Near) Future of the Cannabis Industry -- CFN Media

26/11/2018 - 15:00

SEATTLE, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Advantis Corp Attended the MjBizCon in Las Vegas Last Week and Took the Opportunity to Network with Current and Future Clients and Partners

26/11/2018 - 15:00

NEWPORT BEACH, CA, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) attended the MjBizCon in Las Vegas last week and took the opportunity to network with current and future [...]

Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study

26/11/2018 - 15:00

Topline results for Phase III MicroStat program expected H1 2019 NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of [...]

Tetra Bio-Pharma’s Dr. Chamberland Goes to Washington!

26/11/2018 - 15:00

ORLEANS, Ontario, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the market that Dr. Guy [...]

Teladoc Health Launches Solution to Address Rising Prescription Drug Costs in Canada

26/11/2018 - 14:35

Using advanced analytics, Best Doctors Specialty Pharmacy Services helps employers and insurers identify and help members who would benefit from an expert medical opinion TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- [...]

Genmab to Hold R&D Update and 2018 ASH Data Review Meeting

26/11/2018 - 14:30

Media Release Event to be held live in San Diego, California Independent experts to discuss data presented at the 2018 ASH Annual Meeting Meeting to be webcast live and archived on www.genmab.com Copenhagen, Denmark; [...]

SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Randomized Controlled Clinical Study of Nelipepimut-S Plus Trastuzumab in High-risk, High-expression HER2 Breast Cancer Patients

26/11/2018 - 14:30

Data Expected in Fourth Quarter of 2019 Second Clinical Study of Nelipepimut-S Plus Trastuzumab After Recently Announced Positive Phase 2b Study in Low-expression HER2 or Triple Negative Breast Cancer Study supported by [...]

Anchiano Therapeutics Announces Appointment of Dr. David Kerstein as New Chief Medical Officer

26/11/2018 - 14:30

CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]

Novo Nordisk A/S - Share repurchase programme

26/11/2018 - 14:20

Bagsværd, Denmark, 26 November 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Achaogen Announces Multiple Plazomicin Presentations at the American Society of Health Systems Pharmacists (ASHP) Midyear Clinical Meeting

26/11/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

ITL Pharma Receives United States Patent Protection for Carcinin® Using Halogenated Phenol Ethers for Diagnostics, Antioxidant Protection and Drug Delivery

26/11/2018 - 14:00

KINGSPORT, Tenn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Company, today announced awarding of a United States Patent allowance (S.N. 15/336,179) titled: "Halogenated Phenols for Diagnostic, [...]

Zogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting

26/11/2018 - 14:00

Full Results from Second Pivotal Phase 3 Trial of FINTEPLA ® (ZX008) in Dravet Syndrome (Study 1504) New Long-Term Efficacy and Safety Data from Open-Label Extension Trial (Study 1503) Studies on the Impact of Severe [...]

Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic Dermatitis

26/11/2018 - 14:00

Data Expected in Second Half of 2019 CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO) (“Evelo”) a clinical-stage biotechnology company developing monoclonal microbials to engage [...]

SoldierStrong Announces 2018 SoldierScholar Recipients

26/11/2018 - 14:00

STAMFORD, Conn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced the 2018 recipients of its SoldierScholar [...]

InMode Receives Notice from the FDA of Satisfactory Address of the FDA Letter

26/11/2018 - 14:00

LAKE FOREST, Calif. and YOKNEAM, Israel, Nov. 26, 2018 (GLOBE NEWSWIRE) -- InMode Ltd. announced today that the FDA has advised the company of satisfactory address of all items that appeared in the ‘It Has Come to Our [...]

Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancreatic Cancer

26/11/2018 - 14:00

CALGARY, Alberta and SAN DIEGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced [...]

Tyme Announces the Presentation of Clinical Abstracts at the 2019 Gastrointestinal Cancers Symposium

26/11/2018 - 14:00

NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will present clinical [...]